Our Summary

This research paper is looking at the link between race and the likelihood of having a certain medical procedure, specifically a bilateral salpingo-oophorectomy (BSO; where both ovaries and fallopian tubes are removed), at the same time as a hysterectomy (removal of the uterus). The study was based on data from women treated in the Veterans Affairs (VA) healthcare system between 2007 and 2014.

The study found that, overall, Black veterans were more likely to be single, obese, and to have their hysterectomy performed through an abdominal procedure. However, when the researchers adjusted for these factors, they found that premenopausal (before menopause) Black veterans were 41% less likely to also have a BSO during their hysterectomy than white veterans. This was the case regardless of whether the VA provided or paid for their care.

The researchers didn’t find a similar link for postmenopausal (after menopause) veterans. The study highlights that more research is needed to understand why these racial differences exist, and whether they have implications for fair and equal gynecological care for veterans. They suggest it could be due to different preferences or cancer risk between races.

FAQs

  1. What is a bilateral salpingo-oophorectomy (BSO) and how does it relate to a hysterectomy?
  2. What differences were found between Black and White veterans regarding the likelihood of having a BSO during a hysterectomy?
  3. What are possible reasons for the observed racial differences in the likelihood of undergoing a BSO?

Doctor’s Tip

One helpful tip a doctor might tell a patient about salpingo-oophorectomy is to discuss the potential risks and benefits of the procedure, including the impact on hormone levels, menopause, and future health outcomes. It is important for patients to have a thorough understanding of the procedure and its implications before making a decision.

Suitable For

Patients who are at high risk for ovarian or fallopian tube cancer, such as those with a family history of these cancers or a genetic predisposition (such as BRCA mutations), may be recommended a salpingo-oophorectomy. Additionally, patients with certain gynecological conditions such as ovarian cysts, endometriosis, or pelvic inflammatory disease may also be candidates for this procedure. Patients with a history of breast cancer may also be recommended a salpingo-oophorectomy as a preventive measure, as removing the ovaries can reduce the risk of hormone-sensitive breast cancer recurrence.

Timeline

Before a patient undergoes a salpingo-oophorectomy, they may experience symptoms such as pelvic pain, abnormal bleeding, or a family history of ovarian or breast cancer. They may undergo various diagnostic tests such as ultrasounds, blood tests, or imaging scans to determine the need for the procedure.

After the salpingo-oophorectomy, the patient may experience temporary side effects such as pain, bloating, and fatigue. They will need to follow post-operative care instructions, which may include limitations on physical activity, pain management, and monitoring for any complications. If the ovaries were removed, the patient may experience symptoms of menopause such as hot flashes, mood swings, and changes in libido.

Overall, the patient may experience relief from their initial symptoms and a decreased risk of developing ovarian or fallopian tube-related cancers in the future. Regular follow-up appointments will be necessary to monitor for any potential complications or changes in health.

What to Ask Your Doctor

  1. What is a bilateral salpingo-oophorectomy (BSO) and why is it sometimes performed during a hysterectomy?
  2. Are there any specific risks or benefits associated with having a BSO at the same time as a hysterectomy?
  3. How will the removal of my ovaries and fallopian tubes during the surgery impact my overall health and well-being?
  4. Are there alternative treatments or options to consider instead of having a BSO during my hysterectomy?
  5. How will the removal of my ovaries and fallopian tubes affect my hormonal balance and menopausal symptoms?
  6. Are there any long-term consequences or side effects of having a BSO that I should be aware of?
  7. How will having a BSO during my hysterectomy impact my future fertility and reproductive health?
  8. Are there any specific racial or ethnic factors that may influence the decision to perform a BSO during a hysterectomy?
  9. Are there any disparities or inequalities in the rates of BSO among different racial or ethnic groups that I should be aware of?
  10. Are there any additional resources or support services available to help me make an informed decision about whether to have a BSO during my hysterectomy?

Reference

Authors: Bossick AS, Katon JG, Gray KE, Ma EW, Callegari LS. Journal: J Womens Health (Larchmt). 2020 Dec;29(12):1513-1519. doi: 10.1089/jwh.2020.8503. Epub 2020 Oct 23. PMID: 33095114